Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial.
Shalbafan M, Malekpour F, Tadayon Najafabadi B, Ghamari K, Dastgheib SA, Mowla A, Shirazi E, Eftekhar Ardebili M, Ghazizadeh-Hashemi M, Akhondzadeh S. Shalbafan M, et al. Among authors: ghazizadeh hashemi m. J Psychopharmacol. 2019 Nov;33(11):1407-1414. doi: 10.1177/0269881119878177. Epub 2019 Oct 1. J Psychopharmacol. 2019. PMID: 31575326 Clinical Trial.
L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.
Ghajar A, Khoaie-Ardakani MR, Shahmoradi Z, Alavi AR, Afarideh M, Shalbafan MR, Ghazizadeh-Hashemi M, Akhondzadeh S. Ghajar A, et al. Among authors: ghazizadeh hashemi m. Psychiatry Res. 2018 Apr;262:94-101. doi: 10.1016/j.psychres.2018.02.012. Epub 2018 Feb 3. Psychiatry Res. 2018. PMID: 29427913 Clinical Trial.
Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.
Ghajar A, Gholamian F, Tabatabei-Motlagh M, Afarideh M, Rezaei F, Ghazizadeh-Hashemi M, Akhondzadeh S. Ghajar A, et al. Among authors: ghazizadeh hashemi m. Hum Psychopharmacol. 2018 Jul;33(4):e2662. doi: 10.1002/hup.2662. Epub 2018 Jun 14. Hum Psychopharmacol. 2018. PMID: 29901250 Clinical Trial.
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial.
Masoudi M, Ansari S, Kashani L, Tavolinejad H, Hossein Rashidi B, Esalatmanesh S, Ghazizadeh-Hashemi M, Noorbala AA, Akhondzadeh S. Masoudi M, et al. Among authors: ghazizadeh hashemi m. Int Clin Psychopharmacol. 2021 Sep 1;36(5):238-243. doi: 10.1097/YIC.0000000000000367. Int Clin Psychopharmacol. 2021. PMID: 34030169 Clinical Trial.
Management of Retinal Vein Occlusion, Who Is Responsible?
Aghamirsalim M, Sorbi R, Naderian M, Cugati S, Shahsuvaryan ML, Ghazizadeh Hashemi M. Aghamirsalim M, et al. Among authors: ghazizadeh hashemi m. Acta Med Iran. 2016 Nov;54(11):731-736. Acta Med Iran. 2016. PMID: 28033697 Free article.